Gilead, CVS strike deal on Hepatitis C drugs
January 05, 2015 at 13:47 PM EST
Shares of Gilead Sciences rise more than 2% Monday after the biotechnology giant scores an exclusive rights deal with the nation’s largest drug-store chain, CVS.